CSF-1 receptor signalling from endosomes mediates the sustained activation of Erk1/2 and Akt in macrophages

Cellular Signalling
Jennifer HuynhGlen M Scholz

Abstract

Colony stimulating factor-1 (CSF-1) mediates its pleiotropic effects on macrophages through the CSF-1 receptor (CSF-1R), a receptor tyrosine kinase. Current models of CSF-1 signalling imply that the CSF-1R activates signalling pathways exclusively at the plasma membrane and the subsequent internalisation of the CSF-1R simply facilitates its lysosomal degradation in order to prevent on-going signalling. Here, we sought to establish if the CSF-1R may in fact continue to signal following its internalisation. Erk1/2, Akt and Stat3 activation were abrogated when the internalisation of the CSF-1R was impaired, with the effects on Stat3 distinct from those for Erk1/2 and Akt. Pharmacologic inhibition of the CSF-1R following its internalisation resulted in less sustained Erk1/2 and Akt activity, whereas Stat3 activity was unaffected. Significantly, the suppressive effects of the CSF-1R inhibitor on the up-regulation of gene expression by CSF-1 (e.g. cyclin D1 and Bcl-xL gene expression) were comparable irrespective of whether the inhibitor was added prior to CSF-1 stimulation or following the internalisation of the CSF-1R. Similarly, pharmacologic inhibition of Erk1/2 (or Akt) activity either prior to CSF-1 stimulation or subsequent to...Continue Reading

References

Nov 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·A SenguptaE R Stanley
Jun 1, 1993·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·A Sorkin, C M Waters
Jan 5, 1999·Bioorganic & Medicinal Chemistry Letters·J V DunciaR E Olson
Aug 24, 1999·Cell·J F BrombergJ E Darnell
Feb 28, 2002·Annual Review of Immunology·Charles A Janeway, Ruslan Medzhitov
Apr 30, 2002·Trends in Cell Biology·Boris N Kholodenko
Dec 20, 2002·Nature·Jonathan Cohen
Jan 7, 2004·Nature Reviews. Cancer·Jeffrey W Pollard
Jul 21, 2004·Current Opinion in Cell Biology·Marta MiaczynskaMarino Zerial
Nov 3, 2004·Trends in Cell Biology·Fiona J Pixley, E Richard Stanley
Jan 25, 2005·Bioorganic & Medicinal Chemistry Letters·Craig W LindsleyMark E Duggan
Mar 23, 2005·Current Opinion in Cell Biology·Daniela HoellerIvan Dikic
Oct 27, 2005·Proceedings of the National Academy of Sciences of the United States of America·James G ConwayJeff T Hutchins
Dec 13, 2005·Current Opinion in Immunology·Violeta Chitu, E Richard Stanley
Dec 13, 2005·Current Opinion in Immunology·David A Hume
Jun 3, 2006·Developmental Cell·Eric MaciaTomas Kirchhausen
Jul 31, 2007·Current Opinion in Cell Biology·Mark von Zastrow, Alexander Sorkin
Sep 13, 2007·The Journal of Biological Chemistry·Ana J García-SáezPetra Schwille
Apr 25, 2008·The Journal of Pharmacology and Experimental Therapeutics·James G ConwayThomas A Brodie
Aug 20, 2008·Molecular and Cellular Biology·Adrian AchuthanGlen M Scholz
Sep 10, 2008·The Journal of Cell Biology·Stéphanie Kermorgant, Peter J Parker
Mar 14, 2009·Nature Reviews. Immunology·Jeffrey W Pollard
Oct 14, 2009·Proceedings of the National Academy of Sciences of the United States of America·Jane E MurphyNigel W Bunnett
Jun 7, 2011·Nature Cell Biology·Carine JoffreStéphanie Kermorgant
Oct 15, 2011·Nature Reviews. Immunology·Peter J Murray, Thomas A Wynn

❮ Previous
Next ❯

Citations

Oct 9, 2013·The Journal of Experimental Medicine·Stephen J JenkinsJudith E Allen
Sep 25, 2012·Trends in Immunology·John A Hamilton, Adrian Achuthan
Feb 2, 2017·The Journal of Cell Biology·Michael EbnerIvan Yudushkin
Jul 7, 2018·The Journal of Biological Chemistry·Ksenia BeyrakhovaMiroslaw Cygler
Oct 12, 2019·Cells·Caitrin CruddenLeonard Girnita
Dec 13, 2017·Oncotarget·Min-Ji ChoSeung-Hoon Lee
Aug 18, 2020·Experimental & Molecular Medicine·Se Hwan MunKyung-Hyun Park-Min
Apr 11, 2019·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Sasha A DoodnauthMichelle E Maxson
Oct 23, 2014·Journal of Cell Science·Jieqiong LouAdam D Hoppe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.